 |
SYDNEY, Feb. 25, 2022 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that it has successfully treated its first participant in cohort 2 of the 64Cu/67Cu SARTATE™ neuroblastoma...
The sexual abuse and exploitation of children online is one of the fastest-growing crimes in the world. In the shadows of the digital age, the tide of online child sexual exploitation and abuse is swelling, faster than we can ...
While no means a new form of exercise, the popularity of Pilates is on the rise, particularly post pandemic, with Australian Made Globally loved reformer Pilates franchise Studio Pilates seeing a 149% increase in the number of...
Do you want to enhance your recruiting and selection processes? Make sure you discover candidates that will not only fit in well with the corporate culture, but will also become as enthusiastic about working for your firm as y...